INFI - Infinity Pharmaceuticals receives delisting determination letter from Nasdaq
2023-09-13 11:22:42 ET
More on Infinity Pharmaceuticals
- Financial information for Infinity Pharmaceuticals
- Infinity Pharma cuts jobs, seeking "strategic transaction" for eganelisib
- MEI Pharma postpones special meeting to vote on Infinity deal until July 23
- Proxy advisor ISS recommends MEI, Infinity shareholders approve merger
For further details see:
Infinity Pharmaceuticals receives delisting determination letter from Nasdaq